Episode 10: OIT Safety, OR Anaphylaxis, and IT for Cats

For this episode, we will be reviewing three articles from the Nov-Dec 2019 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. To subscribe to Allergy Watch, head over to https://college.acaai.org/publications/allergywatch

We’re pleased to introduce CME credit for Allergy Watch episodes of AllergyTalk! For details, head on over to the AllergyTalk webpage at https://college.acaai.org/allergytalk

Article Links:

Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.

Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: An observational study.

Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.

Please give us feedback, corrections, and suggestions!

Email feedback to: allergytalk@acaai.org

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Drs. Lee and Kalangara have nothing to disclose.

Dr. Fineman: Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.